EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search (Beta)
All Updates

All Updates

icon
Filter
Partnerships
Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training
Psychedelic Medicine
May 21, 2024
This week:
Robinhood launches joint investment accounts
Retail Trading Infrastructure
Jul 25, 2024
Partnerships
eToro partners with London Stock Exchange to expand UK stock offerings
Retail Trading Infrastructure
Jul 25, 2024
Funding
StorMagic secures funding from Palatine Growth Credit Fund
Edge Computing
Jul 25, 2024
Funding
Archera raises USD 17 million in Series B funding for product development and recruitment
Cloud Optimization Tools
Jul 25, 2024
Funding
Alto Neuroscience receives grant of USD 11.7 million to support Phase IIb clinical trials of ALTO-100
Precision Medicine
Jul 25, 2024
Partnerships
Quest Diagnostics and BD partner to develop flow cytometry-based companion diagnostics for cancer and other diseases
Precision Medicine
Jul 25, 2024
Product updates
USPACE Technology Group Limited unveils commercial optical satellites and related aerospace products
Next-gen Satellites
Jul 25, 2024
Industry news
Sweden issues study on Gripen fighter jet’s satellite launch capability
Next-gen Satellites
Jul 25, 2024
Regulation/policy
‧
Product updates
Terran Orbital receives certification for new manufacturing facility to begin production
Next-gen Satellites
Jul 25, 2024
Partnerships
Crisalion Mobility partners with Air Chateau for pre-order of eVTOL aircraft
Passenger eVTOL Aircraft
Jul 25, 2024
Psychedelic Medicine

Psychedelic Medicine

View industry hub
May 21, 2024

Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training

Partnerships

  • Fluence, a company specializing in psychedelic therapy training, has partnered with Metamorph AI, a technology company, to develop a GenAI tool for psychedelic therapy training.

  • The tool analyzes therapist role-play sessions, identifies areas for improvement, and provides actionable feedback by highlighting missed therapeutic opportunities, flagging deeper engagement possibilities, and generating self-assessment reports. It's integrated into Fluence’s training program to boost training efficiency, and therapy effectiveness while reducing review time for instructors.

  • Analyst QuickTake: Fluence has established several partnerships within the psychedelic industry, including Reunion Neuroscience (April 2024), Psyence (April 2024), Cybin (September 2023), and Tryp Therapeutics (May 2021). The latest partnership with Metamorph AI is expected to enhance the landscape of psychedelic therapy training.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.